Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Irie

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
Chirality|May 29, 2000
Short step enantioselective synthesis of (-)-swainsonineT Punniyamurthy, R Irie, T Katsuki
The Tohoku Journal of Experimental Medicine|May 1, 1987
Expression of alien H-2 and non-H-2 antigens on a murine mammary tumor cell line, MM46H Oshima, S Ishikawa, R Irie, et al.
Journal of Biotechnology|April 14, 1999
DNA sequence comparison considering both amino acid and nucleotide insertions/deletions because of evolution and experimental errorR Irie, S Hiraoka, N Kasahara, et al.
Cancer|May 1, 1979
Rheumatoid factor in melanoma patients: alterations of humoral tumor immunity in vitroA E Giuliano, R Irie, D L Morton
Cancer Investigation|January 1, 1990
Ganglioside composition of human melanoma and response to antitumor treatmentK Kono, T Tsuchida, D H Kern, et al.
Journal of the National Cancer Institute|August 2, 2001
RBP1L1, a retinoblastoma-binding protein-related gene encoding an antigenic epitope abundantly expressed in human carcinomas and normal testisJ Cao, T Gao, E J Stanbridge, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|September 29, 2001
Asymmetric epoxidation with a photoactivated [Ru(salen)] complexK Nakata, T Takeda, J Mihara, et al.
Cancer Letters|June 14, 1991
Inhibitory effects of new types of biflavonoid-related polyphenols; lophirone A and lophiraic acid, on some tumor promoter-induced biological responses in vitro and in vivoA Murakami, H Ohigashi, M Jisaka, et al.
The Tohoku Journal of Experimental Medicine|September 1, 1995
Immunohistological reaction mechanism of anti-monosialoganglioside monoclonal antibody, MAb 202, showing predominant cytotoxicity for malignant melanomaT Ota, M Muto, J Nakano, et al.
Lancet (London, England)|April 18, 1981
S100 protein: a marker for human malignant melanomas?R Gaynor, H R Herschman, R Irie, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Chirality|May 29, 2000
Short step enantioselective synthesis of (-)-swainsonineT Punniyamurthy, R Irie, T Katsuki
The Tohoku Journal of Experimental Medicine|May 1, 1987
Expression of alien H-2 and non-H-2 antigens on a murine mammary tumor cell line, MM46H Oshima, S Ishikawa, R Irie, et al.
Journal of Biotechnology|April 14, 1999
DNA sequence comparison considering both amino acid and nucleotide insertions/deletions because of evolution and experimental errorR Irie, S Hiraoka, N Kasahara, et al.
Cancer|May 1, 1979
Rheumatoid factor in melanoma patients: alterations of humoral tumor immunity in vitroA E Giuliano, R Irie, D L Morton
Cancer Investigation|January 1, 1990
Ganglioside composition of human melanoma and response to antitumor treatmentK Kono, T Tsuchida, D H Kern, et al.
Journal of the National Cancer Institute|August 2, 2001
RBP1L1, a retinoblastoma-binding protein-related gene encoding an antigenic epitope abundantly expressed in human carcinomas and normal testisJ Cao, T Gao, E J Stanbridge, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|September 29, 2001
Asymmetric epoxidation with a photoactivated [Ru(salen)] complexK Nakata, T Takeda, J Mihara, et al.
Cancer Letters|June 14, 1991
Inhibitory effects of new types of biflavonoid-related polyphenols; lophirone A and lophiraic acid, on some tumor promoter-induced biological responses in vitro and in vivoA Murakami, H Ohigashi, M Jisaka, et al.
The Tohoku Journal of Experimental Medicine|September 1, 1995
Immunohistological reaction mechanism of anti-monosialoganglioside monoclonal antibody, MAb 202, showing predominant cytotoxicity for malignant melanomaT Ota, M Muto, J Nakano, et al.
Lancet (London, England)|April 18, 1981
S100 protein: a marker for human malignant melanomas?R Gaynor, H R Herschman, R Irie, et al.
Pageof 3